FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386835412> ?p ?o ?g. }

• W4386835412 endingPage "e16072" @default.
• W4386835412 startingPage "e16072" @default.
• W4386835412 abstract "COVID-19 is a worldwide pandemic caused by the highly infective SARS-CoV-2. There is a need for biomarkers not only for overall prognosis but also for predicting the response to treatments and thus for improvements in the clinical management of patients with COVID-19. Circulating cell-free DNA (cfDNA) has emerged as a promising biomarker in the assessment of various pathological conditions. The aim of this retrospective and observational pilot study was to investigate the range of cfDNA plasma concentrations in hospitalized COVID-19 patients during the first wave of SARS-CoV-2 infection, to relate them to established inflammatory parameters as a correlative biomarker for disease severity, and to compare them with plasma levels in a healthy control group.Lithium-Heparin plasma samples were obtained from COVID-19 patients (n = 21) during hospitalization in the University Medical Centre of Mainz, Germany between March and June 2020, and the cfDNA concentrations were determined by quantitative PCR yielding amplicons of long interspersed nuclear elements (LINE-1). The cfDNA levels were compared with those of an uninfected control group (n = 19).Plasma cfDNA levels in COVID-19 patients ranged from 247.5 to 6,346.25 ng/ml and the mean concentration was 1,831 ± 1,388 ng/ml (± standard deviation), which was significantly different from the levels of the uninfected control group (p < 0.001). Regarding clinical complications, the highest correlation was found between cfDNA levels and the myositis (p = 0.049). In addition, cfDNA levels correlated with the WHO clinical progression scale. D-Dimer and C-reactive protein (CRP) were the clinical laboratory parameters with the highest correlations with cfDNA levels.The results of this observational pilot study show a wide range in cfDNA plasma concentrations in patients with COVID-19 during the first wave of infection and confirm that cfDNA plasma concentrations serve as a predictive biomarker of disease severity in COVID-19." @default.
• W4386835412 created "2023-09-19" @default.
• W4386835412 creator A5020201598 @default.
• W4386835412 creator A5022711291 @default.
• W4386835412 creator A5041141701 @default.
• W4386835412 creator A5041682845 @default.
• W4386835412 creator A5045265780 @default.
• W4386835412 creator A5046410360 @default.
• W4386835412 creator A5058992298 @default.
• W4386835412 creator A5063510802 @default.
• W4386835412 creator A5072195182 @default.
• W4386835412 creator A5075123905 @default.
• W4386835412 creator A5082878585 @default.
• W4386835412 date "2023-09-18" @default.
• W4386835412 modified "2023-10-12" @default.
• W4386835412 title "Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study" @default.
• W4386835412 cites W1985805774 @default.
• W4386835412 cites W2013447783 @default.
• W4386835412 cites W2070816505 @default.
• W4386835412 cites W2091279754 @default.
• W4386835412 cites W2107928264 @default.
• W4386835412 cites W2139461628 @default.
• W4386835412 cites W2164320986 @default.
• W4386835412 cites W2171237493 @default.
• W4386835412 cites W2239118478 @default.
• W4386835412 cites W2264739962 @default.
• W4386835412 cites W2467136872 @default.
• W4386835412 cites W2561358247 @default.
• W4386835412 cites W2622230061 @default.
• W4386835412 cites W2745320320 @default.
• W4386835412 cites W2917613203 @default.
• W4386835412 cites W2937257353 @default.
• W4386835412 cites W2944552292 @default.
• W4386835412 cites W3009885589 @default.
• W4386835412 cites W3014486521 @default.
• W4386835412 cites W3018507926 @default.
• W4386835412 cites W3027918021 @default.
• W4386835412 cites W3028989873 @default.
• W4386835412 cites W3034858522 @default.
• W4386835412 cites W3035695380 @default.
• W4386835412 cites W3046231656 @default.
• W4386835412 cites W3047698180 @default.
• W4386835412 cites W3080840083 @default.
• W4386835412 cites W3081492926 @default.
• W4386835412 cites W3085958090 @default.
• W4386835412 cites W3092136311 @default.
• W4386835412 cites W3092734282 @default.
• W4386835412 cites W3093261446 @default.
• W4386835412 cites W3094099109 @default.
• W4386835412 cites W3104641957 @default.
• W4386835412 cites W3109283769 @default.
• W4386835412 cites W3110402527 @default.
• W4386835412 cites W3111347349 @default.
• W4386835412 cites W3112849794 @default.
• W4386835412 cites W3119793851 @default.
• W4386835412 cites W3121151083 @default.
• W4386835412 cites W3122037590 @default.
• W4386835412 cites W3123730963 @default.
• W4386835412 cites W3128788589 @default.
• W4386835412 cites W3134426305 @default.
• W4386835412 cites W3134914607 @default.
• W4386835412 cites W3134942237 @default.
• W4386835412 cites W3148465672 @default.
• W4386835412 cites W3174549692 @default.
• W4386835412 cites W3193452811 @default.
• W4386835412 cites W4205281901 @default.
• W4386835412 cites W4293514856 @default.
• W4386835412 doi "https://doi.org/10.7717/peerj.16072" @default.
• W4386835412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37744227" @default.
• W4386835412 hasPublicationYear "2023" @default.
• W4386835412 type Work @default.
• W4386835412 citedByCount "0" @default.
• W4386835412 crossrefType "journal-article" @default.
• W4386835412 hasAuthorship W4386835412A5020201598 @default.
• W4386835412 hasAuthorship W4386835412A5022711291 @default.
• W4386835412 hasAuthorship W4386835412A5041141701 @default.
• W4386835412 hasAuthorship W4386835412A5041682845 @default.
• W4386835412 hasAuthorship W4386835412A5045265780 @default.
• W4386835412 hasAuthorship W4386835412A5046410360 @default.
• W4386835412 hasAuthorship W4386835412A5058992298 @default.
• W4386835412 hasAuthorship W4386835412A5063510802 @default.
• W4386835412 hasAuthorship W4386835412A5072195182 @default.
• W4386835412 hasAuthorship W4386835412A5075123905 @default.
• W4386835412 hasAuthorship W4386835412A5082878585 @default.
• W4386835412 hasBestOaLocation W43868354121 @default.
• W4386835412 hasConcept C126322002 @default.
• W4386835412 hasConcept C143998085 @default.
• W4386835412 hasConcept C146304588 @default.
• W4386835412 hasConcept C152110520 @default.
• W4386835412 hasConcept C167135981 @default.
• W4386835412 hasConcept C172680121 @default.
• W4386835412 hasConcept C2778258057 @default.
• W4386835412 hasConcept C2779134260 @default.
• W4386835412 hasConcept C2779234561 @default.
• W4386835412 hasConcept C2781197716 @default.
• W4386835412 hasConcept C3008058167 @default.
• W4386835412 hasConcept C524204448 @default.
• W4386835412 hasConcept C54355233 @default.

• next